medigraphic.com

2007, Number 3

Next >>

Arch Cardiol Mex 2007; 77 (3)

Understanding left ventricular hypertrophy

Guadalajara BJF

Language: Spanish
References: 47
Page: 175-180
PDF size: 150. Kb.


Text Extraction

No abstract


REFERENCES

  1. Levy D, Anderson KM, Savage D, Kannel WB, Christiansen JC, Castelli WP: Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988; 108: 7-13.

  2. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH: Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-178.

  3. Levy D. Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.

  4. Kannel WB, Dannenberg AL, Levy D: Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol, 1987; 60: 851-931.

  5. Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes J, et al: The spectrum of left ventricular hypertrophy in a general population sample: The Framingham Study. Circulation 1987; 75: 126-133.

  6. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.

  7. Schillaci F, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F: Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580-586.

  8. Lund O: Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative intervention. Circulation 1990; 82: 124-34.

  9. Quiñones MA, Greenberg BH, Kopelen HA, Koilpillai C, Limacher MC: Echocardiographic Predictors of Clinical Outcome in Patients With Left Ventricular Dysfunction Enrolled in the SOLVD Registry and Trials: Significance of Left Ventricular Hypertrophy. J Am Coll Cardiol 2000; 35: 1237-44.

  10. Cooper RS, Simmons BE, Castaner A, Santhanam V, Ghali J, Mar M: Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol 1990; 65: 441-445.

  11. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS: The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992; 117: 831-836.

  12. Ghali JK, Liao Y, Cooper RS: Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol 1998; 31: 1635-1640.

  13. Brown AJ Jr: Morphologic factors in cardiac hypertrophy. In: Alpert NR, ed. Cardiac hypertrophy. New York: Academic Press. 1971: 11.

  14. Colan SD, Sanders SP, Borow KM: Physiopathologic hypertrophy: Effects on left ventricular systolic mechanics in athletes. J Am Coll Cardiol 1987; 9: 776-83.

  15. Bar-Shlomo BZ, Druck MN, Morch JE: Left ventricular function in trained and untrained healthy subjects. Circulation 1982; 65: 484-488.

  16. Escudero EM, Pinilla OA: Paradigmas y paradojas de la hipertrofia ventricular izquierda: desde el laboratorio de investigación a la consulta clínica. Arch Cardiol Mex 2007: 77.

  17. Guadalajara JF, Alexanderson E: Remodelación ventricular. Editorial. Arch Inst Cardiol Mex 1993; 63: 85-8.

  18. Guadalajara JF, Galván MO, Camacho P, Espínola N, Cervantes J, Huerta D: Cambios estructurales y funcionales en el corazón del hipertenso. Estudio ecocardiográfico. Arch Inst Cardiol Mex 1995; 65: 31-38.

  19. Guadalajara JF, Martínez SC, Huerta D: La relación grosor/radio del ventrículo izquierdo (h/r) en pacientes con estenosis aórtica. Implicaciones pronósticas y terapéuticas. Arch Inst Cardiol Mex 1990; 60: 383-391.

  20. Osbakken M, Bove A, Span JF: Left ventricular function in chronic aortic regurgitation with reference to systolic pressure/volume and stress relations. Am J Cardiol 1981; 47: 193-8.

  21. Weber KT, Janicki JS: Myocardial oxygen consumption the role of wall force and shortening. Am J Physiol 1977; 233: H421-30.

  22. Guadalajara JF, Gual J, Martínez SC, Monobe F, Alexanderson, Cervantes JL: La hipertrofia miocárdica en la insuficiencia aórtica como mecanismo de compensación. Implicaciones para la indicación quirúrgica. Arch Inst Cardiol Mex 1992; 62: 351-360.

  23. Grossman W: Cardiac hypertrophy: useful adaptation or pathologic process. Am J Med 1980; 69: 576-84.

  24. Gaasch WH: Left ventricular radius to wall thickness ratio. Am J Cardiol 1979; 43: 1189-94.

  25. Guadalajara JF, Martínez C, Gutiérrez PE, Zamora C, Huerta D. et. al: Estudio de la función ventricular mediante la cuantificación de la relación grosor/radio (h/r) del ventrículo izquierdo en sujetos sanos. Arch Inst Cardiol Mex 1989; 59: 293-300.

  26. Benjamin IJ, Schuster EH, Bulkley BH: Cardiac hypertrophy in idiopathic dilated congestive cardiomyopathy: a clinicopathologic study. Circulation 1981; 64: 442-447.

  27. Randhawa AK, Singal PK: Pressure Overload-induced cardiac hypertrophy with and without dilation. J Am Coll Cardiol 1992; 20: 1569-1575.

  28. Carabello BA, Green LH, Grossman W, Cohn l, Koster K, Collins Jr. J: Hemodinamyc determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation 1980; 62: 42-48.

  29. Escudero EM, Tufare AL, Ennis IL, Garciarena CD, Pinilla OA, Carranza VB: Análisis ecocardiográfico del efecto de diferentes inhibidores del intercambiador Na+/H+ sobre la estructura y función sistólica del ventrículo izquierdo en ratas espontáneamente hipertensas. Medicina 2006; 66 (en prensa).

  30. Guadalajara JF, González J, Bucio ER, Pérez P, Cué RJ: La cuantificación no invasiva del estrés parietal sistólico del ventrículo izquierdo en pacientes con insuficiencia cardíaca y su aplicación clínica. Arch Cardiol Mex 2007; 77: 120-129.

  31. Gunther S, Grossman W: Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979; 59: 679-87.

  32. Weber KT: Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 1989; 13: 1637-52.

  33. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-65.

  34. Weber KT, Janicki JS, Shroff SG, Clark WA: Pressure-overload hypertrophy: adaptive and pathologic remodeling of the myocardium. New Frontiers in Cardiovascular Therapy: Focus on Angiotensin Converting Enzyme Inhibition. Excerpta Medica an Elsevier C. 1989: 126-140.

  35. Villardi B, Campbell SE, Hess OM, Mall G, Vassalli G, Weber KT, Krayenbuehl HP: Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol 1993; 22: 1477-84.

  36. Lund O, Kristensen LH, Baandrup U, Hansen OK, Nielsen TT, Emmertsen K, et al: Myocardial structure as a determinant of pre-and postoperative ventricular function and long-term prognosis after valve replacement for aortic stenosis. Eur Heart J 1998; 19: 1099-1108.

  37. Corin WJ, Monrad ES, Murakami T, Nonogi H, Hess OM, Krayenbuehl HP: The relationship of afterload to ejection performance in chronic mitral regurgitation. Circulation 1987; 76: 59-67.

  38. Guadalajara JF, Alexanderson E, Monobe F, Nieto S, Huerta D: La relación grosor/radio (h/r) del ventrículo izquierdo en la insuficiencia mitral pura. Arch Inst Cardiol Mex 1992; 62: 521-528.

  39. Starling MR, Kirsh MM, Montgomery DG, Gross MD: Impaired left ventricular contractile function in patients with long term mitral regurgitation and normal ejection fraction. J Am Coll Cardiol 1993;22:239-250.

  40. Wisenbaugh T, Spann JF, Carabello BA: Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol 1984; 3: 916-923.

  41. Guadalajara JF, Galván Montiel, Noguera M, Alexanderson E, Cervantes JL, Huerta D: El mecanismo de remodelación en las sobrecargas de volumen del ventrículo izquierdo. Arch Inst Cardiol Mex 1995; 65: 217-28.

  42. St. John Sutton MG, Shorpe N: Left ventricular remodeling after myocardial infarction. pathophysiology and therapy. Circulation 2000; 101: 2981-2988.

  43. Guadalajara JF, Valenzuela F, Martínez C, Huerta D: La relación grosor/radio (h/r) en la miocardiopatía hipertrófica y dilatada. Arch Inst Cardiol Mex 1990; 60: 253-260.

  44. Walther T, Shubert A, Falk V, Binner Ch, Walther C, Doll N, et al: Left ventricular reverse remodelin after surgical therapy for aortic stenosis: correlation to renin-angiotensin system gene expression. Circulation 2002; 106(Suppl I): I-23-I-26.

  45. Weber KT, Brilla CG, Campbell SE: Regulatory mechanisms of myocardial hypertrophy and fibrosis: results of in vivo studies. Cardiology 1992; 81: 266-273.

  46. Brilla CG, Janicky JS, Weber KT: Cardioreparative effects of lisinopril in rats genetic hypertension and left ventricular hypertrophy. Circulation 1991a; 83(5): 1771-9.

  47. Brilla CG, Campbell SE, Matsubera L, Weber KT: Advanced hypertensive disease in SHR: Lisinopril mediated regression of myocardial fibrosis. Circulation 1992; 86 (Suppl I): 329 (Abstract).




2020     |     www.medigraphic.com